Considering this, chronic administration of a widely used anti-AD acetylcholinesterase antagonist (i.e., donepezil) was found to elevate serum concentrations of AdipoQ (Pákáski et al., 2014). This evidence concerns the gene ADIPOQ and Alzheimer disease.